

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | V(D)J recombination (GO:0033151) | 6.94345124 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.89112790 |
| 3 | negative regulation of thymocyte apoptotic process (GO:0070244) | 5.80456725 |
| 4 | DNA unwinding involved in DNA replication (GO:0006268) | 5.44177182 |
| 5 | DNA topological change (GO:0006265) | 5.40639103 |
| 6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.72365386 |
| 7 | resolution of meiotic recombination intermediates (GO:0000712) | 4.63279224 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.52285672 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52285672 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.48168297 |
| 11 | eosinophil chemotaxis (GO:0048245) | 4.10430287 |
| 12 | response to hydroperoxide (GO:0033194) | 4.09315827 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.96804489 |
| 14 | T cell migration (GO:0072678) | 3.96058474 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95354722 |
| 16 | COPII vesicle coating (GO:0048208) | 3.94350272 |
| 17 | regulation of RNA export from nucleus (GO:0046831) | 3.88599100 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.87178383 |
| 19 | ribosomal small subunit assembly (GO:0000028) | 3.86933536 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.83125183 |
| 21 | hepatocyte differentiation (GO:0070365) | 3.81955099 |
| 22 | cellular response to ethanol (GO:0071361) | 3.80999117 |
| 23 | interferon-gamma production (GO:0032609) | 3.79453784 |
| 24 | response to interleukin-15 (GO:0070672) | 3.71769357 |
| 25 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.70291590 |
| 26 | omega-hydroxylase P450 pathway (GO:0097267) | 3.63926536 |
| 27 | DNA deamination (GO:0045006) | 3.61934918 |
| 28 | nuclear pore complex assembly (GO:0051292) | 3.61616679 |
| 29 | eosinophil migration (GO:0072677) | 3.58381470 |
| 30 | viral transcription (GO:0019083) | 3.56976200 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 3.53330818 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.51302215 |
| 33 | cellular response to interleukin-15 (GO:0071350) | 3.51069947 |
| 34 | urea metabolic process (GO:0019627) | 3.46249538 |
| 35 | mast cell activation (GO:0045576) | 3.42387407 |
| 36 | somatic cell DNA recombination (GO:0016444) | 3.41634814 |
| 37 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 3.41634814 |
| 38 | nuclear pore organization (GO:0006999) | 3.41201469 |
| 39 | histone monoubiquitination (GO:0010390) | 3.39565503 |
| 40 | translational termination (GO:0006415) | 3.36764853 |
| 41 | positive regulation of macrophage differentiation (GO:0045651) | 3.35796048 |
| 42 | regulation of fibrinolysis (GO:0051917) | 3.34084128 |
| 43 | regulation of regulatory T cell differentiation (GO:0045589) | 3.33236321 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 3.29337640 |
| 45 | L-serine metabolic process (GO:0006563) | 3.27972865 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.27486891 |
| 47 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.27021604 |
| 48 | cotranslational protein targeting to membrane (GO:0006613) | 3.22931952 |
| 49 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.22832655 |
| 50 | sister chromatid segregation (GO:0000819) | 3.21863141 |
| 51 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.21544627 |
| 52 | lymph node development (GO:0048535) | 3.21281151 |
| 53 | protein targeting to ER (GO:0045047) | 3.20391764 |
| 54 | urea cycle (GO:0000050) | 3.20121143 |
| 55 | mature B cell differentiation (GO:0002335) | 3.18624751 |
| 56 | mature B cell differentiation involved in immune response (GO:0002313) | 3.18452468 |
| 57 | glyoxylate metabolic process (GO:0046487) | 3.18157445 |
| 58 | regulation of translation in response to stress (GO:0043555) | 3.17915307 |
| 59 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.17242964 |
| 60 | T cell homeostasis (GO:0043029) | 3.16777214 |
| 61 | positive regulation of interferon-alpha production (GO:0032727) | 3.15648550 |
| 62 | T cell differentiation in thymus (GO:0033077) | 3.15288373 |
| 63 | regulation of histone H3-K9 methylation (GO:0051570) | 3.13341639 |
| 64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.12347398 |
| 65 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.12073961 |
| 66 | response to interferon-beta (GO:0035456) | 3.10877191 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.10865640 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.10865640 |
| 69 | somatic diversification of immune receptors (GO:0002200) | 3.10425505 |
| 70 | response to type I interferon (GO:0034340) | 3.10377345 |
| 71 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.08898512 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08769369 |
| 73 | GTP biosynthetic process (GO:0006183) | 3.07692052 |
| 74 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.07208110 |
| 75 | positive regulation of DNA recombination (GO:0045911) | 3.06518923 |
| 76 | response to protozoan (GO:0001562) | 3.05383414 |
| 77 | protein localization to endoplasmic reticulum (GO:0070972) | 3.04063799 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.03865114 |
| 79 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.03709630 |
| 80 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.02957037 |
| 81 | nitrogen cycle metabolic process (GO:0071941) | 3.02639126 |
| 82 | positive regulation of defense response to virus by host (GO:0002230) | 3.02340090 |
| 83 | pyrimidine dimer repair (GO:0006290) | 3.02333661 |
| 84 | positive regulation of isotype switching (GO:0045830) | 3.00425172 |
| 85 | defense response to protozoan (GO:0042832) | 2.99517963 |
| 86 | purine ribonucleotide transport (GO:0015868) | 2.99411682 |
| 87 | centrosome duplication (GO:0051298) | 2.99255321 |
| 88 | mitotic sister chromatid cohesion (GO:0007064) | 2.97697593 |
| 89 | regulation of female gonad development (GO:2000194) | 2.96674116 |
| 90 | regulation of interferon-alpha production (GO:0032647) | 2.96634344 |
| 91 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.95535590 |
| 92 | negative regulation of cell killing (GO:0031342) | 2.95535590 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.95342866 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.94028649 |
| 95 | regulation of B cell differentiation (GO:0045577) | 2.93706048 |
| 96 | cellular response to virus (GO:0098586) | 2.93630011 |
| 97 | CTP metabolic process (GO:0046036) | 2.91541818 |
| 98 | CTP biosynthetic process (GO:0006241) | 2.91541818 |
| 99 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90460142 |
| 100 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.90151164 |
| 101 | negative regulation of translational initiation (GO:0045947) | 2.89630591 |
| 102 | regulation of thymocyte apoptotic process (GO:0070243) | 2.87387101 |
| 103 | cellular response to interferon-beta (GO:0035458) | 2.86889821 |
| 104 | mitotic chromosome condensation (GO:0007076) | 2.86254723 |
| 105 | respiratory burst (GO:0045730) | 2.84697822 |
| 106 | negative T cell selection (GO:0043383) | 2.83014936 |
| 107 | leukocyte aggregation (GO:0070486) | 2.82523858 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 2.79488520 |
| 109 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.79378071 |
| 110 | response to peptidoglycan (GO:0032494) | 2.78531346 |
| 111 | oxidative demethylation (GO:0070989) | 2.78468377 |
| 112 | formation of translation preinitiation complex (GO:0001731) | 2.77977161 |
| 113 | translational elongation (GO:0006414) | 2.77714819 |
| 114 | positive regulation of granulocyte differentiation (GO:0030854) | 2.77371769 |
| 115 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.75702615 |
| 116 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.75702615 |
| 117 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.75702615 |
| 118 | regulation of centriole replication (GO:0046599) | 2.75560728 |
| 119 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73728112 |
| 120 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.73434720 |
| 121 | myeloid dendritic cell activation (GO:0001773) | 2.73087900 |
| 122 | UTP biosynthetic process (GO:0006228) | 2.73005020 |
| 123 | actin nucleation (GO:0045010) | 2.72513419 |
| 124 | protein localization to chromosome, centromeric region (GO:0071459) | 2.72493465 |
| 125 | signal peptide processing (GO:0006465) | 2.71430747 |
| 126 | rRNA methylation (GO:0031167) | 2.70988095 |
| 127 | response to interferon-alpha (GO:0035455) | 2.70967883 |
| 128 | ribosomal large subunit biogenesis (GO:0042273) | 2.70837185 |
| 129 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.70421771 |
| 130 | NADH dehydrogenase complex assembly (GO:0010257) | 2.70421771 |
| 131 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.70421771 |
| 132 | DNA biosynthetic process (GO:0071897) | 2.70291023 |
| 133 | carnitine shuttle (GO:0006853) | 2.69536199 |
| 134 | response to UV-B (GO:0010224) | 2.68098378 |
| 135 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.67181343 |
| 136 | negative thymic T cell selection (GO:0045060) | 2.66939945 |
| 137 | platelet dense granule organization (GO:0060155) | 2.66114222 |
| 138 | DNA replication initiation (GO:0006270) | 2.63854338 |
| 139 | ER overload response (GO:0006983) | 2.63724587 |
| 140 | apoptotic DNA fragmentation (GO:0006309) | 2.63632036 |
| 141 | negative regulation of cell aging (GO:0090344) | 2.63501209 |
| 142 | cellular response to zinc ion (GO:0071294) | 2.61333866 |
| 143 | mast cell activation involved in immune response (GO:0002279) | 2.60017476 |
| 144 | mast cell degranulation (GO:0043303) | 2.60017476 |
| 145 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.59912361 |
| 146 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.59314645 |
| 147 | positive regulation of B cell mediated immunity (GO:0002714) | 2.59314645 |
| 148 | ribosomal small subunit biogenesis (GO:0042274) | 2.59119733 |
| 149 | glycine metabolic process (GO:0006544) | 2.57994479 |
| 150 | purine nucleobase biosynthetic process (GO:0009113) | 2.57553326 |
| 151 | leukocyte degranulation (GO:0043299) | 2.56590722 |
| 152 | mitotic recombination (GO:0006312) | 2.55366713 |
| 153 | autophagic vacuole fusion (GO:0000046) | 2.54778127 |
| 154 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.53672591 |
| 155 | UTP metabolic process (GO:0046051) | 2.53055531 |
| 156 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.52583206 |
| 157 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.52360931 |
| 158 | T cell lineage commitment (GO:0002360) | 2.52019250 |
| 159 | plasma lipoprotein particle assembly (GO:0034377) | 2.51568129 |
| 160 | viral life cycle (GO:0019058) | 2.51220040 |
| 161 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.50664008 |
| 162 | cellular glucuronidation (GO:0052695) | 2.48842514 |
| 163 | ribosome assembly (GO:0042255) | 2.48239540 |
| 164 | midgut development (GO:0007494) | 2.47805997 |
| 165 | regulation of centrosome cycle (GO:0046605) | 2.45780780 |
| 166 | paraxial mesoderm development (GO:0048339) | 2.44944633 |
| 167 | membrane budding (GO:0006900) | 2.43703618 |
| 168 | protein carboxylation (GO:0018214) | 2.43539713 |
| 169 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.43539713 |
| 170 | regulation of response to tumor cell (GO:0002834) | 2.42747570 |
| 171 | positive regulation of response to tumor cell (GO:0002836) | 2.42747570 |
| 172 | positive regulation of immune response to tumor cell (GO:0002839) | 2.42747570 |
| 173 | regulation of immune response to tumor cell (GO:0002837) | 2.42747570 |
| 174 | histone ubiquitination (GO:0016574) | 2.41329762 |
| 175 | chaperone-mediated protein complex assembly (GO:0051131) | 2.38800615 |
| 176 | epoxygenase P450 pathway (GO:0019373) | 2.38598658 |
| 177 | DNA duplex unwinding (GO:0032508) | 2.38448377 |
| 178 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.37459988 |
| 179 | L-phenylalanine metabolic process (GO:0006558) | 2.37459988 |
| 180 | primitive streak formation (GO:0090009) | 2.36986839 |
| 181 | regulation of protein activation cascade (GO:2000257) | 2.36915010 |
| 182 | rRNA modification (GO:0000154) | 2.35986426 |
| 183 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.35687812 |
| 184 | L-phenylalanine catabolic process (GO:0006559) | 2.35687812 |
| 185 | embryonic process involved in female pregnancy (GO:0060136) | 2.35157975 |
| 186 | spermatid nucleus differentiation (GO:0007289) | 2.30953561 |
| 187 | drug catabolic process (GO:0042737) | 2.30593449 |
| 188 | exogenous drug catabolic process (GO:0042738) | 2.30030830 |
| 189 | nucleobase biosynthetic process (GO:0046112) | 2.29900200 |
| 190 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.28722899 |
| 191 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.28393897 |
| 192 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.28393897 |
| 193 | glucuronate metabolic process (GO:0019585) | 2.26605619 |
| 194 | uronic acid metabolic process (GO:0006063) | 2.26605619 |
| 195 | short-chain fatty acid metabolic process (GO:0046459) | 2.26368486 |
| 196 | polyketide metabolic process (GO:0030638) | 2.26034961 |
| 197 | doxorubicin metabolic process (GO:0044598) | 2.26034961 |
| 198 | daunorubicin metabolic process (GO:0044597) | 2.26034961 |
| 199 | regulation of centrosome duplication (GO:0010824) | 2.25807199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.38439835 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.13061405 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.88589344 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.84885970 |
| 5 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.75332328 |
| 6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.65325102 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16105491 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.14441277 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.12733666 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.98753894 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.96330883 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86251550 |
| 13 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.77947263 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.74469377 |
| 15 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.71581129 |
| 16 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.70070622 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64290372 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.60581495 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.57330837 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.56897879 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.53004525 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49930227 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49649749 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48520018 |
| 25 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.43264186 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 2.41179618 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.35911139 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34689650 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.33644356 |
| 30 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.27650875 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25715436 |
| 32 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.24669688 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22783574 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20699890 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18581104 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 2.16235520 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15085709 |
| 38 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.13529384 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.12085721 |
| 40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.11306077 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.11215365 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10497230 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07520656 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.07455146 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 2.05148811 |
| 46 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.04930124 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03781542 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96671304 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93024670 |
| 50 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.91694843 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89990198 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84832366 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.84497568 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84455604 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.84139453 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.81279018 |
| 57 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.80721597 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80293013 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.74863551 |
| 60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.73379542 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72270130 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.72183053 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70613297 |
| 64 | * MAF_26560356_Chip-Seq_TH1_Human | 1.69997055 |
| 65 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69757582 |
| 66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.68914642 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.66482849 |
| 68 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64128228 |
| 69 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.59699189 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58442302 |
| 71 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.57316990 |
| 72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.55940766 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.55613698 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54584156 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53890586 |
| 76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.52928766 |
| 77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52579337 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49212621 |
| 79 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.49193439 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47798714 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46682098 |
| 82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46129065 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45981014 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.44821105 |
| 85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44679854 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44373314 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42807181 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42693098 |
| 89 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40436136 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39910738 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38229272 |
| 92 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.38190150 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36984118 |
| 94 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.33499857 |
| 95 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.32282004 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32076488 |
| 97 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.30685400 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29387308 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28831314 |
| 100 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27828605 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26615888 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26513856 |
| 103 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25671535 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22210211 |
| 105 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.20121804 |
| 106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20056561 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19659306 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17542132 |
| 109 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16143590 |
| 110 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16055879 |
| 111 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.15333328 |
| 112 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15146099 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15081884 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13965447 |
| 115 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13851409 |
| 116 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12993610 |
| 117 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12611708 |
| 118 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12331191 |
| 119 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12128807 |
| 120 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.12051460 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.11459187 |
| 122 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11257139 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09538207 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09154108 |
| 125 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09109506 |
| 126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09004806 |
| 127 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06857217 |
| 128 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06087935 |
| 129 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.03886168 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03720278 |
| 131 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03589289 |
| 132 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03336546 |
| 133 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02077946 |
| 134 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.98899235 |
| 135 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98716580 |
| 136 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98466474 |
| 137 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98114831 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97836107 |
| 139 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96650311 |
| 140 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96273598 |
| 141 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95495715 |
| 142 | MAF_26560356_Chip-Seq_TH2_Human | 0.94705158 |
| 143 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.94521981 |
| 144 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94319479 |
| 145 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93745760 |
| 146 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93199682 |
| 147 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93187846 |
| 148 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.92739916 |
| 149 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90540690 |
| 150 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90308620 |
| 151 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90282940 |
| 152 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90282940 |
| 153 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90282940 |
| 154 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89967251 |
| 155 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89946642 |
| 156 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89478149 |
| 157 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88876989 |
| 158 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88126473 |
| 159 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87389150 |
| 160 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87346358 |
| 161 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.87004005 |
| 162 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85843844 |
| 163 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84956297 |
| 164 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84142607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 5.69121001 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.11342861 |
| 3 | MP0005671_abnormal_response_to | 3.73685739 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.66503763 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.62654149 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.34640780 |
| 7 | MP0009785_altered_susceptibility_to | 3.05864737 |
| 8 | MP0003890_abnormal_embryonic-extraembry | 3.01481983 |
| 9 | MP0000685_abnormal_immune_system | 2.98841135 |
| 10 | MP0001800_abnormal_humoral_immune | 2.96460461 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.70918648 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.68401761 |
| 13 | MP0003941_abnormal_skin_development | 2.66394234 |
| 14 | MP0003724_increased_susceptibility_to | 2.65940247 |
| 15 | MP0002723_abnormal_immune_serum | 2.57361637 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.56329600 |
| 17 | MP0006082_CNS_inflammation | 2.52467729 |
| 18 | MP0005025_abnormal_response_to | 2.51167662 |
| 19 | MP0001790_abnormal_immune_system | 2.50698832 |
| 20 | MP0005387_immune_system_phenotype | 2.50698832 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.50091827 |
| 22 | MP0002876_abnormal_thyroid_physiology | 2.49957610 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.47780967 |
| 24 | MP0003436_decreased_susceptibility_to | 2.45644285 |
| 25 | MP0001819_abnormal_immune_cell | 2.43978773 |
| 26 | MP0002419_abnormal_innate_immunity | 2.26442954 |
| 27 | MP0002398_abnormal_bone_marrow | 2.25867093 |
| 28 | MP0001873_stomach_inflammation | 2.21480076 |
| 29 | MP0002405_respiratory_system_inflammati | 2.12729271 |
| 30 | MP0005360_urolithiasis | 2.12422534 |
| 31 | MP0000462_abnormal_digestive_system | 2.08298633 |
| 32 | MP0004957_abnormal_blastocyst_morpholog | 2.05029536 |
| 33 | MP0001849_ear_inflammation | 2.04631711 |
| 34 | MP0000716_abnormal_immune_system | 2.03505813 |
| 35 | MP0000689_abnormal_spleen_morphology | 2.00655860 |
| 36 | MP0003718_maternal_effect | 1.94898988 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.93880064 |
| 38 | MP0002722_abnormal_immune_system | 1.92041061 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.91691852 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.90482646 |
| 41 | MP0002006_tumorigenesis | 1.90103103 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.88907616 |
| 43 | MP0008057_abnormal_DNA_replication | 1.87678325 |
| 44 | MP0003077_abnormal_cell_cycle | 1.81055847 |
| 45 | MP0002429_abnormal_blood_cell | 1.75096393 |
| 46 | MP0005408_hypopigmentation | 1.74278261 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.74071886 |
| 48 | MP0003693_abnormal_embryo_hatching | 1.73349002 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.72544597 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.67122065 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.65138595 |
| 52 | MP0003385_abnormal_body_wall | 1.62223878 |
| 53 | MP0008932_abnormal_embryonic_tissue | 1.60767614 |
| 54 | MP0008469_abnormal_protein_level | 1.56081922 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.52955043 |
| 56 | MP0000490_abnormal_crypts_of | 1.50464645 |
| 57 | MP0003011_delayed_dark_adaptation | 1.48291662 |
| 58 | MP0004510_myositis | 1.48086549 |
| 59 | MP0003866_abnormal_defecation | 1.45968682 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.45914897 |
| 61 | MP0008058_abnormal_DNA_repair | 1.44864754 |
| 62 | MP0003252_abnormal_bile_duct | 1.43429588 |
| 63 | MP0001293_anophthalmia | 1.42839098 |
| 64 | MP0010030_abnormal_orbit_morphology | 1.39670998 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.38192899 |
| 66 | MP0009278_abnormal_bone_marrow | 1.34533911 |
| 67 | MP0002933_joint_inflammation | 1.32766432 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.32682919 |
| 69 | MP0003186_abnormal_redox_activity | 1.31850412 |
| 70 | MP0002092_abnormal_eye_morphology | 1.31583025 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.31073537 |
| 72 | MP0001853_heart_inflammation | 1.30189716 |
| 73 | MP0006054_spinal_hemorrhage | 1.28146300 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.27514803 |
| 75 | MP0004084_abnormal_cardiac_muscle | 1.26945511 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.25828860 |
| 77 | MP0003868_abnormal_feces_composition | 1.25797486 |
| 78 | MP0004147_increased_porphyrin_level | 1.25754075 |
| 79 | MP0009053_abnormal_anal_canal | 1.25668605 |
| 80 | MP0004233_abnormal_muscle_weight | 1.22210535 |
| 81 | MP0001730_embryonic_growth_arrest | 1.22005609 |
| 82 | MP0001697_abnormal_embryo_size | 1.19474445 |
| 83 | MP0009379_abnormal_foot_pigmentation | 1.18423086 |
| 84 | MP0009384_cardiac_valve_regurgitation | 1.18252677 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.16632376 |
| 86 | MP0002084_abnormal_developmental_patter | 1.15829480 |
| 87 | MP0001764_abnormal_homeostasis | 1.13999927 |
| 88 | MP0001533_abnormal_skeleton_physiology | 1.13380959 |
| 89 | MP0002009_preneoplasia | 1.12262753 |
| 90 | MP0001986_abnormal_taste_sensitivity | 1.10734853 |
| 91 | MP0005380_embryogenesis_phenotype | 1.08500231 |
| 92 | MP0001672_abnormal_embryogenesis/_devel | 1.08500231 |
| 93 | MP0000762_abnormal_tongue_morphology | 1.08376207 |
| 94 | MP0002233_abnormal_nose_morphology | 1.08287603 |
| 95 | MP0003172_abnormal_lysosome_physiology | 1.08171168 |
| 96 | MP0002086_abnormal_extraembryonic_tissu | 1.07237539 |
| 97 | MP0000343_altered_response_to | 1.06306328 |
| 98 | MP0000350_abnormal_cell_proliferation | 1.04179977 |
| 99 | MP0001879_abnormal_lymphatic_vessel | 1.03591708 |
| 100 | MP0009764_decreased_sensitivity_to | 1.02354038 |
| 101 | MP0005310_abnormal_salivary_gland | 1.01634729 |
| 102 | MP0002088_abnormal_embryonic_growth/wei | 1.00000324 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99799022 |
| 104 | MP0001851_eye_inflammation | 0.99465668 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.99432848 |
| 106 | MP0000858_altered_metastatic_potential | 0.99394623 |
| 107 | MP0002160_abnormal_reproductive_system | 0.98922802 |
| 108 | MP0001915_intracranial_hemorrhage | 0.98839065 |
| 109 | MP0003984_embryonic_growth_retardation | 0.97955164 |
| 110 | MP0009763_increased_sensitivity_to | 0.97954914 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 0.96681867 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.96636852 |
| 113 | MP0005197_abnormal_uvea_morphology | 0.96495751 |
| 114 | MP0005397_hematopoietic_system_phenotyp | 0.95619864 |
| 115 | MP0001545_abnormal_hematopoietic_system | 0.95619864 |
| 116 | MP0002080_prenatal_lethality | 0.94800757 |
| 117 | MP0002697_abnormal_eye_size | 0.94481392 |
| 118 | MP0002075_abnormal_coat/hair_pigmentati | 0.94433976 |
| 119 | MP0005367_renal/urinary_system_phenotyp | 0.94261742 |
| 120 | MP0000516_abnormal_urinary_system | 0.94261742 |
| 121 | MP0005220_abnormal_exocrine_pancreas | 0.93507899 |
| 122 | MP0004197_abnormal_fetal_growth/weight/ | 0.92691179 |
| 123 | MP0003828_pulmonary_edema | 0.92001469 |
| 124 | MP0003937_abnormal_limbs/digits/tail_de | 0.90746079 |
| 125 | MP0003123_paternal_imprinting | 0.88106317 |
| 126 | MP0002019_abnormal_tumor_incidence | 0.87737492 |
| 127 | MP0009672_abnormal_birth_weight | 0.86900581 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.86883959 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.86726470 |
| 130 | MP0005551_abnormal_eye_electrophysiolog | 0.85795539 |
| 131 | MP0005623_abnormal_meninges_morphology | 0.83984293 |
| 132 | MP0002060_abnormal_skin_morphology | 0.83545548 |
| 133 | MP0003315_abnormal_perineum_morphology | 0.83321620 |
| 134 | MP0000372_irregular_coat_pigmentation | 0.83082512 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.81365974 |
| 136 | MP0004272_abnormal_basement_membrane | 0.80918918 |
| 137 | MP0002085_abnormal_embryonic_tissue | 0.80034751 |
| 138 | MP0005501_abnormal_skin_physiology | 0.79922802 |
| 139 | MP0001286_abnormal_eye_development | 0.79138575 |
| 140 | MP0009697_abnormal_copulation | 0.78009119 |
| 141 | MP0000609_abnormal_liver_physiology | 0.76059255 |
| 142 | MP0001340_abnormal_eyelid_morphology | 0.75796085 |
| 143 | MP0006138_congestive_heart_failure | 0.75718796 |
| 144 | MP0002132_abnormal_respiratory_system | 0.75491007 |
| 145 | MP0002998_abnormal_bone_remodeling | 0.75067659 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.74933490 |
| 147 | MP0003942_abnormal_urinary_system | 0.74836175 |
| 148 | MP0003448_altered_tumor_morphology | 0.74796366 |
| 149 | MP0005391_vision/eye_phenotype | 0.74633582 |
| 150 | MP0005076_abnormal_cell_differentiation | 0.72480745 |
| 151 | MP0005319_abnormal_enzyme/_coenzyme | 0.72374349 |
| 152 | MP0008007_abnormal_cellular_replicative | 0.72122024 |
| 153 | MP0001727_abnormal_embryo_implantation | 0.71905023 |
| 154 | MP0003755_abnormal_palate_morphology | 0.71605747 |
| 155 | MP0004947_skin_inflammation | 0.71588494 |
| 156 | MP0003705_abnormal_hypodermis_morpholog | 0.71177224 |
| 157 | MP0005253_abnormal_eye_physiology | 0.70904558 |
| 158 | MP0001661_extended_life_span | 0.70643080 |
| 159 | MP0006292_abnormal_olfactory_placode | 0.70489797 |
| 160 | MP0001186_pigmentation_phenotype | 0.69414252 |
| 161 | MP0005166_decreased_susceptibility_to | 0.68774283 |
| 162 | MP0004782_abnormal_surfactant_physiolog | 0.68135273 |
| 163 | MP0003300_gastrointestinal_ulcer | 0.67610309 |
| 164 | MP0003699_abnormal_female_reproductive | 0.67267360 |
| 165 | MP0005395_other_phenotype | 0.67220767 |
| 166 | MP0001663_abnormal_digestive_system | 0.65177410 |
| 167 | MP0003303_peritoneal_inflammation | 0.64970822 |
| 168 | MP0006072_abnormal_retinal_apoptosis | 0.64784688 |
| 169 | MP0001881_abnormal_mammary_gland | 0.64633271 |
| 170 | MP0003935_abnormal_craniofacial_develop | 0.64216881 |
| 171 | MP0009765_abnormal_xenobiotic_induced | 0.63706830 |
| 172 | MP0000733_abnormal_muscle_development | 0.63673354 |
| 173 | MP0002095_abnormal_skin_pigmentation | 0.62655272 |
| 174 | MP0005365_abnormal_bile_salt | 0.62632282 |
| 175 | MP0003075_altered_response_to | 0.61967649 |
| 176 | MP0008873_increased_physiological_sensi | 0.60760754 |
| 177 | MP0000598_abnormal_liver_morphology | 0.60085331 |
| 178 | MP0003943_abnormal_hepatobiliary_system | 0.57592069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoproteinemia (HP:0003075) | 7.47143786 |
| 2 | Erythroderma (HP:0001019) | 4.56661940 |
| 3 | Myositis (HP:0100614) | 4.56618508 |
| 4 | Eosinophilia (HP:0001880) | 4.56400332 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.01559641 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.72773590 |
| 7 | Ankyloglossia (HP:0010296) | 3.72167371 |
| 8 | IgM deficiency (HP:0002850) | 3.57937397 |
| 9 | Recurrent bronchitis (HP:0002837) | 3.51822663 |
| 10 | T lymphocytopenia (HP:0005403) | 3.38176433 |
| 11 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 3.36498032 |
| 12 | Hypothermia (HP:0002045) | 3.29126448 |
| 13 | Abnormality of T cells (HP:0002843) | 3.26488795 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.22879959 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.22604760 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.21351922 |
| 17 | Recurrent viral infections (HP:0004429) | 3.20143777 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.19681923 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.18400018 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.06402042 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.06402042 |
| 22 | Optic neuritis (HP:0100653) | 3.05442362 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.05442362 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.04098514 |
| 25 | Meningitis (HP:0001287) | 2.98625143 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 2.96740990 |
| 27 | Severe combined immunodeficiency (HP:0004430) | 2.96118331 |
| 28 | Orchitis (HP:0100796) | 2.95956256 |
| 29 | Encephalitis (HP:0002383) | 2.94207845 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 2.91768540 |
| 31 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.90615214 |
| 32 | Recurrent sinusitis (HP:0011108) | 2.89702221 |
| 33 | Thyroiditis (HP:0100646) | 2.89676123 |
| 34 | Chronic otitis media (HP:0000389) | 2.88160239 |
| 35 | Reduced antithrombin III activity (HP:0001976) | 2.86033530 |
| 36 | Chronic sinusitis (HP:0011109) | 2.84651127 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.83161324 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82357385 |
| 39 | Agammaglobulinemia (HP:0004432) | 2.81780814 |
| 40 | Recurrent skin infections (HP:0001581) | 2.79192569 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78521197 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78521197 |
| 43 | Hypoplasia of the thymus (HP:0000778) | 2.74442487 |
| 44 | Aplastic anemia (HP:0001915) | 2.74100282 |
| 45 | Severe visual impairment (HP:0001141) | 2.69938963 |
| 46 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.69834620 |
| 47 | Petechiae (HP:0000967) | 2.67223009 |
| 48 | Abnormality of complement system (HP:0005339) | 2.66454355 |
| 49 | IgG deficiency (HP:0004315) | 2.65775150 |
| 50 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.61781669 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.60672348 |
| 52 | Reticulocytopenia (HP:0001896) | 2.59055191 |
| 53 | Prolonged partial thromboplastin time (HP:0003645) | 2.58700630 |
| 54 | B lymphocytopenia (HP:0010976) | 2.58409349 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.58409349 |
| 56 | Abnormality of the thymus (HP:0000777) | 2.57638065 |
| 57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.57081253 |
| 58 | Abnormality of oral frenula (HP:0000190) | 2.56618482 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.54202197 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.53445911 |
| 61 | Cerebral palsy (HP:0100021) | 2.53038450 |
| 62 | Combined immunodeficiency (HP:0005387) | 2.51974339 |
| 63 | Thrombocytosis (HP:0001894) | 2.45792273 |
| 64 | Type I transferrin isoform profile (HP:0003642) | 2.45190316 |
| 65 | Hepatic necrosis (HP:0002605) | 2.43684371 |
| 66 | Abnormal tarsal ossification (HP:0008369) | 2.42796435 |
| 67 | Abnormal pancreas size (HP:0012094) | 2.42009526 |
| 68 | Generalized aminoaciduria (HP:0002909) | 2.40387846 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39086098 |
| 70 | Obstructive lung disease (HP:0006536) | 2.39086098 |
| 71 | Pustule (HP:0200039) | 2.38819081 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.37526184 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.37341228 |
| 74 | Papillary thyroid carcinoma (HP:0002895) | 2.36204975 |
| 75 | Gingival bleeding (HP:0000225) | 2.35312945 |
| 76 | Chin dimple (HP:0010751) | 2.35168618 |
| 77 | Epistaxis (HP:0000421) | 2.33586551 |
| 78 | Papilledema (HP:0001085) | 2.32204166 |
| 79 | Chronic diarrhea (HP:0002028) | 2.32142690 |
| 80 | Abnormal number of erythroid precursors (HP:0012131) | 2.30456099 |
| 81 | Lymphopenia (HP:0001888) | 2.30104749 |
| 82 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.24380709 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.23601896 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 2.20710910 |
| 85 | Vasculitis (HP:0002633) | 2.20567195 |
| 86 | Stomatitis (HP:0010280) | 2.18832156 |
| 87 | Agnosia (HP:0010524) | 2.18831654 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.18613906 |
| 89 | Septate vagina (HP:0001153) | 2.17493637 |
| 90 | Abnormality of methionine metabolism (HP:0010901) | 2.17180904 |
| 91 | Nasal polyposis (HP:0100582) | 2.16714537 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 2.15398831 |
| 93 | Purpura (HP:0000979) | 2.14806882 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 2.14154553 |
| 95 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.13782685 |
| 96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12774803 |
| 97 | Abnormal foot bone ossification (HP:0010675) | 2.11749732 |
| 98 | Keratoconjunctivitis (HP:0001096) | 2.10556000 |
| 99 | Pallor (HP:0000980) | 2.10405512 |
| 100 | Abnormality of eosinophils (HP:0001879) | 2.10340770 |
| 101 | Attenuation of retinal blood vessels (HP:0007843) | 2.10185701 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 2.06439674 |
| 103 | Bronchitis (HP:0012387) | 2.06427938 |
| 104 | Recurrent pneumonia (HP:0006532) | 2.05997172 |
| 105 | Pancytopenia (HP:0001876) | 2.05683244 |
| 106 | Multiple enchondromatosis (HP:0005701) | 2.05134323 |
| 107 | Congenital stationary night blindness (HP:0007642) | 2.04878797 |
| 108 | Granulocytopenia (HP:0001913) | 2.04170370 |
| 109 | Joint swelling (HP:0001386) | 2.03338372 |
| 110 | Lymphoma (HP:0002665) | 2.03168087 |
| 111 | Increased cerebral lipofuscin (HP:0011813) | 2.03148093 |
| 112 | Pulmonary infiltrates (HP:0002113) | 2.01627551 |
| 113 | Albinism (HP:0001022) | 2.01533363 |
| 114 | Thoracic kyphosis (HP:0002942) | 2.00943068 |
| 115 | Abnormal hair whorl (HP:0010721) | 1.99507210 |
| 116 | Birth length less than 3rd percentile (HP:0003561) | 1.97607329 |
| 117 | Hypoplasia of the pons (HP:0012110) | 1.95939675 |
| 118 | Hemoptysis (HP:0002105) | 1.95916144 |
| 119 | Microcytic anemia (HP:0001935) | 1.95563895 |
| 120 | Osteomalacia (HP:0002749) | 1.94010885 |
| 121 | Mitochondrial inheritance (HP:0001427) | 1.93919191 |
| 122 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93663810 |
| 123 | Constricted visual fields (HP:0001133) | 1.93529077 |
| 124 | Cellulitis (HP:0100658) | 1.93486135 |
| 125 | Acute lymphatic leukemia (HP:0006721) | 1.86430788 |
| 126 | Neoplasm of the colon (HP:0100273) | 1.84677494 |
| 127 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83729832 |
| 128 | Adrenal hypoplasia (HP:0000835) | 1.77842406 |
| 129 | Spontaneous abortion (HP:0005268) | 1.77353042 |
| 130 | Anal stenosis (HP:0002025) | 1.76456296 |
| 131 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.74534537 |
| 132 | Pruritus (HP:0000989) | 1.73284690 |
| 133 | Hyperlipoproteinemia (HP:0010980) | 1.72732396 |
| 134 | Megaloblastic anemia (HP:0001889) | 1.72142159 |
| 135 | Conjugated hyperbilirubinemia (HP:0002908) | 1.71870612 |
| 136 | Bifid uvula (HP:0000193) | 1.70670718 |
| 137 | Chromsome breakage (HP:0040012) | 1.70572914 |
| 138 | Gout (HP:0001997) | 1.70149465 |
| 139 | Thyroid carcinoma (HP:0002890) | 1.69787773 |
| 140 | Intrahepatic cholestasis (HP:0001406) | 1.69731736 |
| 141 | Abnormality of the pons (HP:0007361) | 1.67374379 |
| 142 | Vaginal fistula (HP:0004320) | 1.65984046 |
| 143 | Hyperammonemia (HP:0001987) | 1.64659689 |
| 144 | Hypolipoproteinemia (HP:0010981) | 1.64468666 |
| 145 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.63389357 |
| 146 | Termporal pattern (HP:0011008) | 1.60031641 |
| 147 | Insidious onset (HP:0003587) | 1.60031641 |
| 148 | Sepsis (HP:0100806) | 1.59927783 |
| 149 | Acute myeloid leukemia (HP:0004808) | 1.59457492 |
| 150 | Abnormality of the common coagulation pathway (HP:0010990) | 1.59434709 |
| 151 | Cellular immunodeficiency (HP:0005374) | 1.58684911 |
| 152 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.57956150 |
| 153 | Lower limb hyperreflexia (HP:0002395) | 1.55430200 |
| 154 | Leukocytosis (HP:0001974) | 1.55320827 |
| 155 | Abnormality of the nasal septum (HP:0000419) | 1.55019560 |
| 156 | Overlapping toe (HP:0001845) | 1.54579693 |
| 157 | Gonadotropin excess (HP:0000837) | 1.54487411 |
| 158 | Acanthocytosis (HP:0001927) | 1.54037690 |
| 159 | Preauricular pit (HP:0004467) | 1.52847285 |
| 160 | Periauricular skin pits (HP:0100277) | 1.52847285 |
| 161 | Macrocytic anemia (HP:0001972) | 1.50599685 |
| 162 | Nephritis (HP:0000123) | 1.49533413 |
| 163 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.47568789 |
| 164 | Small epiphyses (HP:0010585) | 1.46891010 |
| 165 | Septo-optic dysplasia (HP:0100842) | 1.45556548 |
| 166 | Increased mean platelet volume (HP:0011877) | 1.45429584 |
| 167 | Skin rash (HP:0000988) | 1.45164139 |
| 168 | Hepatoblastoma (HP:0002884) | 1.43470788 |
| 169 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.41288979 |
| 170 | Short tibia (HP:0005736) | 1.40782629 |
| 171 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.40365376 |
| 172 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.40365376 |
| 173 | Abnormal protein glycosylation (HP:0012346) | 1.40365376 |
| 174 | Abnormal glycosylation (HP:0012345) | 1.40365376 |
| 175 | Rectovaginal fistula (HP:0000143) | 1.39617615 |
| 176 | Rectal fistula (HP:0100590) | 1.39617615 |
| 177 | Squamous cell carcinoma (HP:0002860) | 1.38946561 |
| 178 | Premature ovarian failure (HP:0008209) | 1.36801184 |
| 179 | Methylmalonic acidemia (HP:0002912) | 1.34812239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MET | 3.85811776 |
| 2 | NME2 | 3.80800590 |
| 3 | MAP4K1 | 3.22707985 |
| 4 | TXK | 2.87884872 |
| 5 | TEC | 2.77983018 |
| 6 | IRAK4 | 2.77370776 |
| 7 | TYK2 | 2.66128904 |
| 8 | TNIK | 2.62630433 |
| 9 | MAP3K14 | 2.51547256 |
| 10 | KIT | 2.47511758 |
| 11 | NLK | 2.42078894 |
| 12 | BLK | 2.41805984 |
| 13 | BMPR1B | 2.27366676 |
| 14 | MST1R | 2.23981879 |
| 15 | BTK | 2.20435631 |
| 16 | CDK12 | 2.16111943 |
| 17 | TTK | 2.09471607 |
| 18 | IKBKE | 2.08286083 |
| 19 | JAK3 | 2.06281583 |
| 20 | FLT3 | 1.98784475 |
| 21 | ZAP70 | 1.88128327 |
| 22 | CDC7 | 1.85656598 |
| 23 | CSF1R | 1.81612847 |
| 24 | ITK | 1.70584350 |
| 25 | CDK6 | 1.70298370 |
| 26 | EIF2AK1 | 1.69592278 |
| 27 | TBK1 | 1.68833926 |
| 28 | MAP3K13 | 1.67740129 |
| 29 | SYK | 1.63440827 |
| 30 | ICK | 1.59725883 |
| 31 | MAPK15 | 1.55126787 |
| 32 | CDK19 | 1.54886216 |
| 33 | LCK | 1.54344149 |
| 34 | FES | 1.50267680 |
| 35 | EIF2AK3 | 1.50123813 |
| 36 | TAOK3 | 1.50114893 |
| 37 | CDK7 | 1.49176642 |
| 38 | TRIM28 | 1.47076390 |
| 39 | PIM2 | 1.41426034 |
| 40 | PIK3CG | 1.39652044 |
| 41 | TGFBR1 | 1.38807527 |
| 42 | NEK1 | 1.37538772 |
| 43 | GRK6 | 1.31280046 |
| 44 | JAK1 | 1.30002077 |
| 45 | STK10 | 1.28231429 |
| 46 | NEK9 | 1.28167739 |
| 47 | MAP2K3 | 1.26704468 |
| 48 | HCK | 1.24914843 |
| 49 | VRK1 | 1.24672267 |
| 50 | IKBKB | 1.23683780 |
| 51 | BRD4 | 1.23493190 |
| 52 | FGFR4 | 1.20314680 |
| 53 | IRAK3 | 1.20132029 |
| 54 | EPHA2 | 1.20109081 |
| 55 | SCYL2 | 1.18597423 |
| 56 | ERBB4 | 1.14563554 |
| 57 | PIM1 | 1.14337890 |
| 58 | ADRBK2 | 1.14211040 |
| 59 | PKN2 | 1.12682416 |
| 60 | LYN | 1.11362918 |
| 61 | TGFBR2 | 1.09352040 |
| 62 | LATS1 | 1.05774605 |
| 63 | ARAF | 1.04913066 |
| 64 | CLK1 | 1.04652902 |
| 65 | DYRK3 | 1.03959793 |
| 66 | SIK3 | 1.01438781 |
| 67 | RPS6KB1 | 1.00877622 |
| 68 | PLK4 | 0.99983815 |
| 69 | MAP3K10 | 0.99303325 |
| 70 | CSK | 0.99121259 |
| 71 | BCR | 0.98183454 |
| 72 | NEK2 | 0.97858665 |
| 73 | PBK | 0.97308482 |
| 74 | KDR | 0.94650778 |
| 75 | AURKB | 0.90941371 |
| 76 | PAK2 | 0.90785102 |
| 77 | ZAK | 0.90634239 |
| 78 | ACVR1B | 0.87376958 |
| 79 | MAP3K8 | 0.87107898 |
| 80 | IRAK1 | 0.87079201 |
| 81 | AURKA | 0.86564887 |
| 82 | FGFR3 | 0.86522686 |
| 83 | CHEK2 | 0.84680286 |
| 84 | HIPK2 | 0.82209983 |
| 85 | PLK1 | 0.80468570 |
| 86 | DYRK1B | 0.79806115 |
| 87 | MUSK | 0.79592254 |
| 88 | WEE1 | 0.79440797 |
| 89 | AKT3 | 0.78358582 |
| 90 | RAF1 | 0.77932342 |
| 91 | STK24 | 0.77522903 |
| 92 | RPS6KB2 | 0.77365893 |
| 93 | TLK1 | 0.74966606 |
| 94 | ATR | 0.74871900 |
| 95 | TIE1 | 0.74826820 |
| 96 | YES1 | 0.74471389 |
| 97 | JAK2 | 0.73117112 |
| 98 | CHEK1 | 0.70260336 |
| 99 | BRSK2 | 0.69939604 |
| 100 | SIK1 | 0.69931886 |
| 101 | RPS6KA4 | 0.69926936 |
| 102 | MAPK11 | 0.69122897 |
| 103 | MAP2K7 | 0.68739264 |
| 104 | MAP3K12 | 0.66571365 |
| 105 | GRK7 | 0.65293478 |
| 106 | MAPKAPK5 | 0.65265077 |
| 107 | TNK2 | 0.63369761 |
| 108 | BMPR2 | 0.62927182 |
| 109 | STK3 | 0.62863451 |
| 110 | MAP3K7 | 0.62630602 |
| 111 | RIPK4 | 0.62191617 |
| 112 | CDK3 | 0.61942936 |
| 113 | CDK2 | 0.61825721 |
| 114 | RPS6KA5 | 0.60975292 |
| 115 | PRKCQ | 0.60019633 |
| 116 | ATM | 0.60006190 |
| 117 | MKNK1 | 0.59833052 |
| 118 | PDK2 | 0.59814166 |
| 119 | EIF2AK2 | 0.59496209 |
| 120 | EEF2K | 0.58911094 |
| 121 | PLK3 | 0.58535081 |
| 122 | CDK8 | 0.57953702 |
| 123 | CSNK1E | 0.57800739 |
| 124 | EPHA3 | 0.57652139 |
| 125 | TRPM7 | 0.56927065 |
| 126 | PDGFRA | 0.56112151 |
| 127 | CAMKK2 | 0.55769431 |
| 128 | MARK3 | 0.55718517 |
| 129 | PIK3CA | 0.54738856 |
| 130 | PASK | 0.53781469 |
| 131 | MST4 | 0.53221642 |
| 132 | BUB1 | 0.52959758 |
| 133 | TAF1 | 0.52936826 |
| 134 | MAPK4 | 0.52898503 |
| 135 | MAP2K6 | 0.52498368 |
| 136 | LATS2 | 0.51965132 |
| 137 | CAMK1 | 0.51951875 |
| 138 | CDK9 | 0.51939311 |
| 139 | MTOR | 0.51480845 |
| 140 | CSNK2A2 | 0.50810032 |
| 141 | RPS6KA6 | 0.50071143 |
| 142 | NEK6 | 0.49628344 |
| 143 | CSNK2A1 | 0.48051330 |
| 144 | CDK4 | 0.47657363 |
| 145 | MOS | 0.47593505 |
| 146 | FRK | 0.46345226 |
| 147 | CDK1 | 0.46160330 |
| 148 | SRPK1 | 0.45421481 |
| 149 | TYRO3 | 0.45349440 |
| 150 | ERN1 | 0.43772458 |
| 151 | LRRK2 | 0.42604851 |
| 152 | RIPK1 | 0.42384933 |
| 153 | STK16 | 0.41558212 |
| 154 | OBSCN | 0.41409669 |
| 155 | MAP3K9 | 0.41332395 |
| 156 | RPS6KC1 | 0.40201784 |
| 157 | RPS6KL1 | 0.40201784 |
| 158 | BCKDK | 0.38436711 |
| 159 | CSNK1G1 | 0.38409526 |
| 160 | PRKG2 | 0.37787427 |
| 161 | ABL1 | 0.36768580 |
| 162 | ILK | 0.33188377 |
| 163 | MKNK2 | 0.29952424 |
| 164 | EGFR | 0.29845530 |
| 165 | MELK | 0.29589586 |
| 166 | MAP3K2 | 0.29088972 |
| 167 | CSNK1A1L | 0.28935714 |
| 168 | GSK3B | 0.27714225 |
| 169 | MAP3K5 | 0.27228804 |
| 170 | AKT2 | 0.25668640 |
| 171 | MAP3K4 | 0.24323151 |
| 172 | KSR1 | 0.24266434 |
| 173 | MYLK | 0.23124862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.06460639 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.53928649 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.78056669 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44719068 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.41074717 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.39303211 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.33538920 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.22482133 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15355602 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14646006 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.12763596 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10881794 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08998894 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.07995222 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.07791224 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01755279 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01627211 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98213428 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97197617 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.91254904 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85591615 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75052038 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72153745 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.71683584 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71450713 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.71394838 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70875815 |
| 28 | Cell cycle_Homo sapiens_hsa04110 | 1.70464165 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.68320767 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68306395 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66221992 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60467889 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59496276 |
| 34 | Mismatch repair_Homo sapiens_hsa03430 | 1.57052001 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.56417380 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55198021 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55159564 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54274039 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52428943 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51783256 |
| 41 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48823354 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48248341 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48160093 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43929548 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43281404 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41067451 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38594574 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36040365 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34908783 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.34823054 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31776841 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31462198 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24609453 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.23824439 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19502164 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17974604 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16900029 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16499684 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15129258 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 1.15095705 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 1.14624933 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 1.13749658 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12560774 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11391562 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11084105 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10652308 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 1.07330756 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 1.05640927 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.04999967 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02711566 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00811695 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.99887600 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99757689 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99348855 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.98139012 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97959515 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97015533 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95883359 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95567895 |
| 80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.95166175 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95111945 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94627761 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93785207 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93656325 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.90249975 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89748173 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89375811 |
| 88 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88410516 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87896544 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87604065 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.86187503 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85844206 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85207269 |
| 94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84276446 |
| 95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.84115243 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81723650 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.80476927 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76651109 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.75636998 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75294458 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.75111781 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74943870 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.73342306 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71188597 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67827578 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66909458 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66771853 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66342818 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.65999167 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65339311 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64350880 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63912767 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63807595 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62875929 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60666062 |
| 116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60505510 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59239198 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57773375 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56657739 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.56237782 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55893473 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55097537 |
| 123 | Malaria_Homo sapiens_hsa05144 | 0.54147384 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53311751 |
| 125 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52761697 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52726429 |
| 127 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51930097 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50659159 |
| 129 | ABC transporters_Homo sapiens_hsa02010 | 0.49947815 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49776855 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47945030 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47703470 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47478812 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.46589407 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.46515413 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44290397 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44201377 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43188554 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42492966 |
| 140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41856259 |
| 141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41638327 |
| 142 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40615735 |
| 143 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40487934 |
| 144 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40454494 |
| 145 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39395186 |
| 146 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38208569 |
| 147 | Lysine degradation_Homo sapiens_hsa00310 | 0.37098886 |
| 148 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36695167 |
| 149 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36554417 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35273109 |
| 151 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34245191 |
| 152 | Phagosome_Homo sapiens_hsa04145 | 0.33227856 |
| 153 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32054235 |
| 154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31240971 |
| 155 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30522756 |
| 156 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29590214 |
| 157 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29462015 |

